231 related articles for article (PubMed ID: 37306442)
1. Prevalence, Cost, and Burden of Diabetic Ketoacidosis.
Virdi N; Poon Y; Abaniel R; Bergenstal RM
Diabetes Technol Ther; 2023 Jun; 25(S3):S75-S84. PubMed ID: 37306442
[TBL] [Abstract][Full Text] [Related]
2. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy.
Dull RB; Spangler ML; Knezevich EL; Lau BM
J Pharm Pract; 2019 Apr; 32(2):240-243. PubMed ID: 29241389
[TBL] [Abstract][Full Text] [Related]
3. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial.
Laffel LM; Wentzell K; Loughlin C; Tovar A; Moltz K; Brink S
Diabet Med; 2006 Mar; 23(3):278-84. PubMed ID: 16492211
[TBL] [Abstract][Full Text] [Related]
4. Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes.
Peters AL; Henry RR; Thakkar P; Tong C; Alba M
Diabetes Care; 2016 Apr; 39(4):532-8. PubMed ID: 26989182
[TBL] [Abstract][Full Text] [Related]
5. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors.
Fleming N; Hamblin PS; Story D; Ekinci EI
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32302001
[TBL] [Abstract][Full Text] [Related]
6. Beyond type 2 diabetes: sodium glucose co-transporter-inhibition in type 1 diabetes.
Biester T; Kordonouri O; Danne T
Diabetes Obes Metab; 2019 Apr; 21 Suppl 2():53-61. PubMed ID: 31081591
[TBL] [Abstract][Full Text] [Related]
7. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Burke KR; Schumacher CA; Harpe SE
Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
[TBL] [Abstract][Full Text] [Related]
8. SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort.
Ata F; Yousaf Z; Khan AA; Razok A; Akram J; Ali EAH; Abdalhadi A; Ibrahim DA; Al Mohanadi DHSH; Danjuma MI
Sci Rep; 2021 May; 11(1):10293. PubMed ID: 33986421
[TBL] [Abstract][Full Text] [Related]
9. Can we prevent diabetic ketoacidosis in children?
Bismuth E; Laffel L
Pediatr Diabetes; 2007 Oct; 8 Suppl 6():24-33. PubMed ID: 17727382
[TBL] [Abstract][Full Text] [Related]
10. Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature.
Bonora BM; Avogaro A; Fadini GP
Diabetes Obes Metab; 2018 Jan; 20(1):25-33. PubMed ID: 28517913
[TBL] [Abstract][Full Text] [Related]
11. Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis.
Stougaard EB; Kristensen PL; Kielgast U; Andersen HU; Hamid Y; Gæde PH; Søndergaard E; Dørflinger GH; Fjeldborg KK; Hansen KW; Thomsen HH; Al-Imar TMJ; Røder M; Sridhar VS; Cherney D; Rossing P; Persson F
Diab Vasc Dis Res; 2022; 19(5):14791641221130043. PubMed ID: 36262089
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Clinical Characteristics of Adults Presenting With Sodium-Glucose Cotransporter-2 Inhibitor-Associated Diabetic Ketoacidosis at a Canadian Academic Tertiary Care Hospital.
Clark A; Mohammed AS; Raut A; Moore S; Houlden R; Awad S
Can J Diabetes; 2021 Apr; 45(3):214-219. PubMed ID: 33046401
[TBL] [Abstract][Full Text] [Related]
13. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Danne T; Garg S; Peters AL; Buse JB; Mathieu C; Pettus JH; Alexander CM; Battelino T; Ampudia-Blasco FJ; Bode BW; Cariou B; Close KL; Dandona P; Dutta S; Ferrannini E; Fourlanos S; Grunberger G; Heller SR; Henry RR; Kurian MJ; Kushner JA; Oron T; Parkin CG; Pieber TR; Rodbard HW; Schatz D; Skyler JS; Tamborlane WV; Yokote K; Phillip M
Diabetes Care; 2019 Jun; 42(6):1147-1154. PubMed ID: 30728224
[TBL] [Abstract][Full Text] [Related]
14. The performance of a glucose-ketone meter in the diagnosis of diabetic ketoacidosis in patients with type 2 diabetes in the emergency room.
Voulgari C; Tentolouris N
Diabetes Technol Ther; 2010 Jul; 12(7):529-35. PubMed ID: 20597827
[TBL] [Abstract][Full Text] [Related]
15. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression.
Musso G; Sircana A; Saba F; Cassader M; Gambino R
PLoS Med; 2020 Dec; 17(12):e1003461. PubMed ID: 33373368
[TBL] [Abstract][Full Text] [Related]
16. Sodium-Glucose Cotransporter-2 Inhibitor-associated Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing Coronary Artery Bypass Grafting Surgery.
Chaudhry A; Roels C; Lee J
Can J Diabetes; 2022 Dec; 46(8):843-850. PubMed ID: 36068154
[TBL] [Abstract][Full Text] [Related]
17. Acute Metabolic Emergencies in Diabetes: DKA, HHS and EDKA.
Muneer M; Akbar I
Adv Exp Med Biol; 2021; 1307():85-114. PubMed ID: 32488607
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Case for the Integration of a Ketone Sensor as Part of a Closed Loop Insulin Pump System.
Lee MH; Paldus B; Krishnamurthy B; McAuley SA; Shah R; Jenkins AJ; O'Neal DN
J Diabetes Sci Technol; 2019 Sep; 13(5):967-973. PubMed ID: 30628470
[TBL] [Abstract][Full Text] [Related]
19. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.
Sarno MJF; Hernandez DPF; Matulac MO
Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of quantitative capillary beta-hydroxybutyrate measurement in the diagnosis of diabetic ketoacidosis: a comparison to quantitative serum ketone measurement by nitroprusside reaction.
Lertwattanarak R; Plainkum P
J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S78-85. PubMed ID: 24772583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
